PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling 5,771 shares, a drop of 83.7% from the September 15th total of 35,490 shares. Based on an average daily volume of 138,958 shares, the days-to-cover ratio is currently 0.0 days.
PharmaTher Price Performance
OTCMKTS:PHRRF traded down $0.00 on Friday, reaching $0.04. 20,000 shares of the company’s stock were exchanged, compared to its average volume of 157,653. The stock has a fifty day simple moving average of $0.04 and a 200-day simple moving average of $0.04. PharmaTher has a 52 week low of $0.03 and a 52 week high of $0.14.
About PharmaTher
PharmaTher Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for diseases with significant unmet medical needs. The company’s strategy centers on repurposing established medicines and advancing pharmaceutical products through clinical development and regulatory pathways.
PharmaTher has primarily focused on ketamine-based treatments and psychedelic medicines. Its development programs have included potential applications of ketamine in neurological and psychiatric conditions, including status epilepticus, Parkinson’s disease and related movement disorders.
Read More
- Five stocks we like better than PharmaTher
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
